CTSA Renewal Celebration

From left: Jonathan Holloway, President, Rutgers University; Mark Manigan, CEO, RWJBarnabas Health; Brian Strom, Chancellor, Rutgers Health; Governor Phil Murphy; Shawna Hudson, Vice Chancellor for Translational Medicine and Science Director, Rutgers Health; Reynold Panettieri, Vice Chancellor for Translational Medicine and Science, Rutgers Health. Photo: Luca Mostello

NJ ACTS Receives 7-year Grant Renewal of $39.7M

Translating scientific discoveries  into improved health in New Jersey and beyond 

 

Join Our Clinical Research Investigator Registry

The Registry can match investigators with new clinical trial opportunities!

 

Advancing clinical and translational science to develop new therapies and treatments and improve health care

Become a Member

NJ ACTS is dedicated to leading the development of new approaches to the health problems of New Jersey and to translating those advances into therapies and treatments.

Find a Clinical Trial

Rutgers supports nearly 350 clinical trials at any given time. Our Rutgers Clinical Research Organization is the gateway to our statewide clinical trial activities

Funding Opportunities

NJ ACTS disseminates information on funding opportunities to its members and partner institutions, directly through emails and our website.

NJ ACTS Services & SRB

NJ ACTS Cores offer consulting, tools and other services to its members and partner institutions.

EVENTS


NEWS


Interested in Accessing Clinical Data?

Join us for an "Introduction to the Clinical and Research Data Warehouse, presented by Branimir Ljubic, Senior Scientist in Rutgers' Office of Advanced Research Computing. These sessions will discuss what the CRDW is, what data it contains, where it is housed, the...

VIDEO HIGHLIGHTS

Dr. Reynold Panettieri on "What to know about the next generation of COVID-19 vaccines"